A placebo controlled study of the effect of extended treatment with rituximab on resistant rheumatoid arthritis: Clinical and radiological outcomes
Phase of Trial: Phase IV
Latest Information Update: 17 Jan 2014
At a glance
- Drugs Rituximab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms EXTRRA
- 04 Sep 2010 Status changed from recruiting to completed as reported by ISRCTN: Current Controlled Trials.
- 16 Jun 2010 Results have been presented at the 11th Annual Congress of the European League Against Rheumatism.
- 14 Apr 2008 New trial record.